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Aim: We investigated pathological characteristics of adrenal involvement in patients who underwent radical
nephrectomy (RN) for renal cell carcinoma (RCC).
Materials and Methods: 49 patients (34 male, 15 female) who underwent RN and simultaneous ipsilateral
adrenalectomy due to RCC were included. Patient and tumor characteristics, histopathologic features, disease
stage, and radiologic computerized tomography (CT) features were studied in order to see if any of them are
associated with pathological evidence of adrenal involvement.
Results: Presence of adrenal irregularity (P = 0.002), venous thrombosis (P = 0.010), tumor necrosis (P =
0.031), and lymph node (LN) involvement (P = 0.013) on CT, increased Fuhrman grade (P = 0.037), and
presence of capsular invasion (P = 0.027) and perirenal fatty tissue invasion by RCC (P = 0.011) were found
to be significantly associated with ipsilateral adrenal involvement. There was no statistically significant
association with location of the tumor in the upper pole of the kidney (P = 0.077), increased tumor size (P =
0.098), pathologic stage (P = 0.085), presence of vascular invasion (P = 0.067), and metastasis despite
higher incidence of them in the group with adrenal involvement.
Conclusions: Risk factors for ipsilateral adrenal involvement by RCC appear to be the presence of adrenal
gland irregularity, venous thrombosis and necrosis on CT, increased Fuhrman grade, presence of capsular and
peripheral fatty tissue invasion, LN involvement, and metastasis. Therefore, we recommend ipsilateral
adrenalectomy particularly in this patient group.
Key Words: Renal cancer, adrenal involvement, risk factors

Renal Hücreli Karsinom Nedeni ile Radikal Nefrektomi Yapılan Hastalarda
Adrenal Bezi Tutulumunu Etkileyen Faktörler
Amaç: Bu çalışmada renal hücreli karsinom (RHK) nedeniyle radikal nefrektomi (RN) yaptığımız olgularda
adrenal tutulumun patolojik özellikleri incelenmiştir.
Yöntem ve Gereç: RHK nedeniyle RN ve ipsilateral adrenalektomi yaptığımız 49 olgu (34 erkek, 15 bayan)
çalışmaya alınmıştır. Hasta ve tümör özellikleri, histopatolojik bulgular, hastalık evresi ve bilgisayarlı
tomografi (BT) bulguları değerlendirilerek patolojik olarak adrenal tutulum ile ilişkileri araştırılmıştır.
Bulgular: BT’de adrenal düzensizlik (P = 0.002), venöz trombüs (P = 0.010), tümör nekrozu (P = 0.031),
lenf nodu (LN) tutulumu (P = 0.013) olması; artmış Fuhrman derecesi (P = 0.037), kapsüler invazyon (P =
0.027) ve perirenal yağ dokusu invazyonu (P = 0.011) olması, ipsilateral adrenal tutulumu ile anlamlı olarak
ilişkili bulunmuştur. Tümörün böbrek üst polde yerleşmesi (P = 0.077), artmış tümör boyutu (P = 0.098),
patolojik evre (P = 0.085), vasküler invazyon varlığı (P = 0.067) ve metastaz varlığı, her ne kadar adrenal
tutulumu olan grupta artmış olarak saptansa da istatistiksel olarak anlamlı bulunmamıştır.
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Sonuç: BT’de adrenal düzensizlik, venöz trombüs, nekroz varlığı, artmış Fuhrman derecesi, kapsüler
invazyon, perirenal yağ dokusu invazyonu, LN tutulumu ve metastaz varlığı ipsilateral adrenal tutulumu için
risk faktörleridir. Bu hastalarda RN ile birlikte ipsilateral adrenalektomi yapılmasını öneriyoruz.
Anahtar Sözcükler: Renal kanser, adrenal tutulum, risk faktörleri
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Introduction
Renal cell carcinoma (RCC) accounts for 3% of all adult solid tumors (1) and radical
nephrectomy (RN) with ipsilateral adrenalectomy has been the standard for its surgical
treatment, which was first described by Robson in 1963 (2). Currently, most of the
RCCs are being detected incidentally by their smaller size due to improved radiologic
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imaging modalities and their frequent use leading to
increased RCC incidence worldwide (3) at an earlier stage
and with less associated lymph node and adrenal
involvement (4). Therefore, there is a tendency to
perform nephron sparing surgery (NSS) rather than RN
in suitable kidney tumors (5).

vascular invasion), disease stage (pathologic stage,
presence of LN involvement, and metastasis), and
radiologic findings on CT (presence of adrenal gland
abnormalities, tumor necrosis, and venous thrombosis)
and how they correlate with adrenal involvement was
investigated.

Malignant involvement of the ipsilateral adrenal gland
by RCC has been reported to be between 1% and 10%
of RN specimens and up to 23% in autopsy series (6).
Therefore, unnecessary removal of the adrenal gland
seems to be overtreatment in almost 90% of cases.
Preassessment of the adrenal gland and definition of risk
factors associated with adrenal involvement is important
for the urologist, which could prevent unnecessary
adrenalectomies. In this regard, we retrospectively
investigated factors affecting adrenal gland involvement
in patients who underwent RN for RCC, its incidence, and
preoperative computerized tomography (CT) findings,
which might allow the surgeon to select patients for
adrenal sparing surgery.

On CT scans, tumor laterality (right/left), tumor size
(≤7 cm, >7 cm), tumor localization (upper/mid/lower
poles), presence of lymphadenopathy, necrosis or venous
thrombosis, and adrenal gland abnormalities (irregularity,
enlarged diameter, mass lesion, heterogeneous density,
contiguous infiltration) were noted. Preoperative CT
findings were compared with histopathologic results in
order to evaluate the accuracy of CT in detecting adrenal
involvement by RCC.

Materials and Methods
Between 2004 and 2007, 49 patients (34 male, 15
female) who underwent RN and simultaneous ipsilateral
adrenalectomy due to renal cancer were included in our
study.
Diagnosis
of
RCC
was
confirmed
histopathologically in all patients. Mean patient age was
57 years (range, 19-88), and 34 (69%) patients were
males and 15 (31%) were females. All patients have
undergone preoperative abdominal ultrasound (USG), CT,
and chest X-ray for staging. We performed NSS in
patients with a kidney mass of <4 cm in size therefore,
we did not include these patients in our study. RN was
performed with adrenalectomy and retroperitoneal lymph
node (LN) dissection at the level of renal hilus in all
patients. If pathologic enlarged LNs are detected on
preoperative
CT
or
intraoperatively
then
lymphadenectomy was extended to include paracaval and
interaortacaval lymph nodes for right sided tumors and
para-aortic lymph nodes for left sided tumors.
We retrospectively reviewed the patient charts
regarding the following parameters: patient
demographics (gender and age), tumor characteristics
(tumor localization, laterality, and size), histopathologic
features (histologic type, Fuhrman grade, presence of
capsular invasion, peripheral fatty tissue invasion, and
216

Pathologic staging was performed according to the
histopathologic examination of the tumor with the
evaluation of renal capsule, perirenal fatty tissue, renal
vein, regional lymph nodes and Gerota’s fascia in terms of
the presence of tumor invasion by using TNM 2002
guidelines (7). Tumor size was measured as the
maximum diameter on CT scans. Capsular invasion,
peripheral renal tissue (perirenal fat) invasion, and
vascular invasion were also evaluated and verified
microscopically.
Statistical analysis was performed using SPSS 11.5.
Data regarding patient age was presented as mean ±
standard deviation and Fuhrman grade was presented as
median (minimum, maximum). Significance between the
groups was analyzed by Mann Whitney U test.
Comparison of the categories was performed using Chi
square and Fisher’s exact tests. P < 0.05 was considered
statistically significant.

Results
Renal tumors were located in the upper, mid, and
lower poles of the kidneys in 51%, 31%, and 18% of
cases, respectively. Of the 49 patients, 6 (12.3%) had
ipsilateral adrenal involvement by RCC. No contralateral
or bilateral adrenal involvement was detected by
preoperative radiologic evaluation including US and CT.
There were 4 (11.8%) adrenal metastases in the males
and 2 (13.3%) in the females (Table 1). No significant
relationship concerning patient demographics (age and
gender) was detected between the group of patients with
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and without adrenal involvement (P > 0.05) (Table 1).
Correlation between tumor characteristics (tumor
localization, size, and laterality), radiologic features
(adrenal gland abnormalities, presence of tumor necrosis,
and venous thrombosis on CT) and adrenal involvement
are summarized in Table 1. Tumor size, location, and
laterality did not seem to affect adrenal involvement in our
study (P > 0.05). However, the presence of adrenal
irregularity, necrosis and venous thrombosis were found
to be significant risk factors for adrenal involvement
(Table 1). Presence of necrosis on CT was also confirmed
histopathologically after RN in all patients. Although the
presence of adrenal irregularity on CT was significantly
associated with adrenal involvement (Table 1), of the 6
patients with adrenal involvement, CT did not demonstrate
any abnormality despite metastasis was confirmed
histopathologically in 2 patients. Therefore, CT
demonstrates 66.7% sensitivity, 93.0% specifity, 57.1%
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positive predictive value, and 93.0% negative predictive
value for detection of adrenal involvement when correlated
with pathologic examination of the adrenal glands.
Table 2 shows the correlation between
histopathologic features (histologic type, Fuhrman grade,
presence of capsular invasion, perirenal fat invasion, and
vascular invasion) and adrenal gland involvement.
Presence of capsular invasion, perirenal fat invasion, and
increased Fuhrman grade were found to be significantly
associated with adrenal gland involvement by RCC;
however, vascular invasion and histologic tumor type
were not found to be associated with adrenal
involvement. Relationship between disease stage
(including pathologic stage, presence of lymph node
involvement, and metastasis) and adrenal gland
involvement is demonstrated on Table 2. Among these
variables, only the presence of LN involvement was a
significant risk factor.

Table 1. Comparison of patient demographics, tumor characteristics, and radiologic findings with adrenal
gland involvement. CT: Computerized tomography.

Presence of adrenal gland involvement
P
(-)
n = 43

(+)
n=6

30 (69.8%)
13 (30.2%)
58.2 ± 12.35

4 (66.7%)
2 (33.3%)
51.5 ± 17.9

Upper pole
Mid pole
Lower pole

20 (46.5%)
15 (34.9%)
8 (18.6%)

5 (83.3%)
1 (16.7)

Tumor Laterality

Right
Left

23 (53.5%)
20 (46.5%)

5 (83.3%)
1 (16.7%)

0.219

Tumor Size

4-7 cm
>7cm

24 (55.8%)
19 (44.2%)

1 (16.7%)
5 (83.3%)

0.098

Radiologic CT Findings
Adrenal gland
(-)
Irregularity
(+)

40 (93.0%)
3 (7.0%)

2 (33.3%)
4 (66.7%)

0.002

Presence of venous
thrombosis

(-)
(+)

41 (95.3%)
2 (4.7%)

3 (50%)
3 (50%)

0.010

Presence of necrosis

(-)
(+)

22 (51.2%)
21 (48.8%)

6 (100%)

0.031

Patient Demographics
Gender
Male
Female
Age

1.000
0.247

Tumor Characteristics
Tumor Localization

0.077
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Table 2. Comparison of histopathologic findings and disease stage with adrenal gland involvement status.
LN: Lymph node.

Presence of adrenal gland involvement
P
(-)
n = 43

(+)
n=6

36 (83.3%)

6 (100%)

Papillary

16 (14%)

-

Chromophobe cell

1 (2.3%)

-

2 (1-4)

3 (2-4)

0.037

Histopathologic Findings
Clear cell
Histologic Type

Fuhrman Grade

0.371

Capsular invasion

(-)
(+)

22 (51.2%)
21 (48.8%)

6 (100%)

0.027

Perirenal fatty
tissue invasion

(-)
(+)

32 (74.4%)
11 (25.6%)

1 (16.7%)
5 (83.3%)

0.011

Vascular invasion

(-)
(+)

37 (86%)
6 (14%)

3 (50%)
3 (50%)

0.067

T1a

7 (16.3%)

1 (16.7%)

Disease Stage
T1b

17 (39.5%)

-

T2

4 (9.3%)

1 (16.7%)

T3a

11 (25.6%)

1 (16.7%)

T3b

4 (9.3%)

3 (50%)

Presence of LN
involvement

(-)
(+)

43 (100%)
-

2 (33.3%)
4 (66.7%)

0.013

Presence of metastasis

(-)
(+)

43 (100%)
-

5 (83.3%)
1 (16.7%)

0.122

Pathologic stage

Discussion
RCC might involve adrenal gland and ipsilateral
adrenalectomy with RN was suggested previously (2).
However, currently most of the renal tumors are being
detected incidentally with their smaller size as a localized
disease and, therefore, the need for adrenalectomy is
questioned both in the presence of a normal appearing
adrenal gland on preoperative radiological evaluation and
as an intraoperative finding. Based on these, we
investigated tumor related, pathological, and radiological
factors that might affect adrenal involvement in patients
with RCC.
218

0.085

I. Patient demographics and adrenal involvement
No association was detected between patient age,
gender, and adrenal involvement by RCC in our study
(Table 1) in accordance with other studies (8,9). Alamdari
et al. suggested male gender as a risk factor for ipsilateral
adrenal metastasis by RCC (10).
II. Tumor characteristics and adrenal involvement
Tumor localization in the kidney
It has been suggested that adrenal metastasis might
be due to local invasion by continuous growth,
particularly for the upper pole tumors, or by
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hematogenous spread for mid and lower pole tumors
(10,11). Therefore, tumors located in the upper pole of
the kidney, which are anatomically closely related with
the adrenal glands, were suggested to have an increased
risk of adrenal metastasis (11,12). It is also suggested
that, due to the presence of vessels that transverse the
fibrous septum between the adrenal gland and the upper
pole of the kidney providing a direct route for RCC cells,
adrenal involvement is more commonly seen in upper pole
kidney tumors (13). However, controversial reports exist
in the literature. For example, although some studies
failed to find an association between the location of the
tumor in the kidney and adrenal involvement (8-10,14),
others suggested that diffuse involvement of the kidney
(8) or even a tendency towards lower pole tumors (15)
as risk factors. In our study, 83.3% of the patients with
upper pole kidney tumors had adrenal involvement, which
did not reach the level of statistical significance (Table 1).
Tumor laterality
Due to common venous drainage of the upper pole of
the left kidney with the adrenal gland, it was suggested
that left sided kidney tumors have an increased risk for
adrenal metastasis (9,16,17). In opposition to others
who did not report an association (8,10), von Knobloch
et al. reported even a higher percent of adrenal
involvement for the right sided kidney tumors in a series
of 589 patients (15). In our study, we did not find any
relationship between tumor laterality and adrenal
involvement (Table 1). Therefore, association of tumor
laterality and adrenal involvement appear to be
controversial.
Tumor size
Tumor size was found to be a significant risk factor
for adrenal involvement in the literature (10). Siemer et
al. recommended adrenalectomy in patients with a
primary tumor >4 cm in size (8), whereas Paul et al.
suggested adrenalectomy in greater than 8 cm sized
tumors (9). However, others reported that correlation of
tumor size and adrenal involvement was not statistically
significant in their series including more than 500 cases
(11,12). In our study, no association was detected
between tumor size and adrenal metastases although
patients with tumors >7 cm size have an increased rate
of adrenal metastases, which was not significant (P >
0.05) (Table 1). Thus, debatable reports exist regarding
tumor size and adrenal involvement in the literature.
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Tumor multifocality
Although we did not evaluate the impact of number of
tumors in the kidney (tumor multifocality) on adrenal
involvement, controversial papers exist. Paul et al. failed
to demonstrate the number of tumors as a risk factor of
adrenal involvement in a series of 866 patients (9),
whereas others reported that multifocal tumors in the
kidney were associated with an increased risk of adrenal
metastasis (11,18).
III. Radiologic features and adrenal involvement
Adrenal gland irregularity on CT
CT is an important radiologic modality in the
evaluation of adrenal involvement by RCC. Detection of
adrenal abnormalities, such as irregularity, enlarged
diameter, mass lesion, nodule formation, heterogeneous
density, non-visualization, and contiguous infiltration,
should alert the urologist for possible adrenal metastasis.
In our series, out of 6 patients with adrenal involvement,
preoperative CT revealed adrenal irregularity in 4
patients and did not demonstrate any abnormality in the
rest 2 patients although involvement by RCC was
confirmed histopathologically. The presence of adrenal
irregularity on CT was significantly associated with
adrenal metastasis (Table 1). Therefore, CT
demonstrates 66.7% sensitivity, 93.0% specifity, 57.1%
positive predictive value, and 93.0% negative predictive
value for detection of adrenal involvement in our study.
Our results seems to be similar to the previously
published series particularly having large number of
patients (Table 3) (11,12,19). Tsui et al. reported that,
in the presence of an adrenal mass, its size is a significant
risk factor for adrenal involvement (11).
Apart from the abnormal appearance of the adrenal
gland on CT, attenuation in non-contrast-enhanced slices
(Hounsfield Unit, [HU]) might have an importance in the
radiological evaluation of adrenal lesions (20). It was
suggested that adrenal lesions <0 HU might be
considered as benign, 0-15 HU probably benign, and >15
HU indeterminate lesions (20). On the other hand,
magnetic resonance imaging (MRI) might also be useful
and add more information to CT in the detection of
adrenal metastasis particularly when CT is unreliable
(21).
Atan et al. published a series of 198 patients with
RCC, who were treated with RN and ipsilateral
adrenalectomy including 5 different urology departments
219
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Table 3. Comparison of published series concerning evaluation of adrenal glands by CT in patients with
RCC in the lietarature. PPV: Positive predictive value, NPV: Negative predictive value.
Authors (Ref)

N

Sensitivity

Specifity

PPV

NPV

210

87%

97.7%

80%

98.4%

Tsui et al. (11)

511

99.6%

89.6%

92.8%

99.4%

Antonelli et al. (19)

1179

47%

99%

73%

96%

49

66.7%

93.0%

57.1%

93.0%

Moudouni et al. (12)

Our study

investigating the role of CT for detecting the number of
tumors and adrenal gland involvement in patients with
renal cell cancer (22). They reported that preoperative
abnormal CT findings were less reliable for detecting
tumor multifocality and adrenal gland involvement. Due
to their histopathological evaluation, preoperative CT
findings missed adrenal gland involvement and multifocal
tumor in 4.7% and 4.3% of the patients, respectively.
They concluded that although CT seems to be a reliable
diagnostic tool for detecting adrenal gland involvement
and tumor multifocality, more sophisticated radiological
imaging methods or specific marker(s) are needed.
Presence of venous thrombosis on CT
Involvement of the renal vein by tumor thrombus has
been suggested as a risk factor for adrenal involvement
by several studies (11,12,23). Similarly, in our study, the
presence of venous thrombosis was found to be
significantly associated with adrenal involvement (Table
1). Tsui et al. reported that the risk of adrenal metastasis
by RCC increased particularly in the presence of left renal
vein thrombosis, which might be due to common venous
drainage of the left adrenal and left kidney (11).
However, Moudouni et al. found no significant correlation
between left renal vein thrombus and adrenal
involvement (12).
Presence of necrosis on CT
In our study, all of the patients with adrenal
involvement were detected to have necrosis in their
kidney tumors and the presence of necrosis was found to
be a significant risk factor for adrenal metastasis (Table
1). To the best of our knowledge, our study is the first
that investigates the impact of necrosis on adrenal
involvement, which we think might be an important
finding in the evaluation of kidney tumors.
220

IV. Histopathologic features and adrenal gland
involvement by RCC
Histologic type
Tumor cell type was not found to be associated with
adrenal involvement in our study (Table 2). All of the 6
patients with adrenal involvement had clear cell RCC in
their kidneys. Siemer et al. also reported that tumor
histology (cell type) did not affect adrenal metastasis in
their series of 1635 patients (8).
Fuhrman grade
Currently, Fuhrman grading is the most frequently
used histologic grading system in RCC, which is
associated with local recurrence, pathologic stage, and
survival (24). However, few studies have investigated the
role of Fuhrman grade on adrenal gland involvement in
the literature. In our study, increased Fuhrman grade was
found to be significantly associated with adrenal gland
involvement (Table 2). Ito et al. reported that, of the 12
patients with adrenal involvement by RCC, 3 had grade 3
(25%), 8 had grade 2 (67%), and 1 had (8%) disease in
their series (25).
Capsular and perirenal fatty tissue invasion
Tumors extending to perirenal tissues, such as
capsular and perirenal fat invasion (locally advanced
disease), were considered as significant risk factors for
adrenal involvement by RCC (10,19). Similarly, capsular
and perirenal fatty tissue invasion were detected to be
associated with ipsilateral adrenal involvement in our
study (Table 2).
Vascular invasion
Although vascular invasion within the primary tumor
was considered as an independent variable for predicting
metastatic involvement of the adrenal gland by several
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Table 4. Factors affecting adrenal gland involvement by RCC. RCC: Renal cell carcinoma, LN:
Lymph node.
Significant risk factors for adrenal gland involvement by RCC
1.

Adrenal gland irregularity on CT (P = 0.002)

2.

Presence of venous thrombosis on CT (P = 0.010)

3.

Presence of tumor necrosis on CT (P = 0.031)

4.

Presence of LN involvement by RCC (P = 0.013)

5.

Increased Fuhrman grade (P = 0.037)

6.

Presence of capsular invasion by RCC (P = 0.027)

7.

Presence of peripheral fat tissue invasion by RCC (P = 0.011)
Possible risk factors for adrenal gland involvement by RCC

1.

Location of the tumor in the upper pole of the kidney (P = 0.077)

2.

Tumor size (P = 0.098)

3.

Vascular invasion (P = 0.067)

4.

Pathologic stage (P = 0.085)

studies (10,18), it was not found to be significantly
associated with ipsilateral adrenal involvement, which
might be due to the limited number of patients in the
present study (Table 2).
Pathologic stage
Adrenal metastasis from primary RCC was found
significantly more often in patients with advanced tumor
stages by previous studies with larger number of patients
(8,12,26,27). Tsui et al. reported that tumor stage
correlated with the probability of adrenal spread, with
T1-2, T3, and T4 tumors accounting for 0.6%, 7.8%,
and 40% of cases, respectively (11). However, in our
study no significant association was detected between
tumor stage and adrenal involvement by RCC, which we
think might be due to the limited number of patients with
adrenal involvement in our study (Table 2).
A recent study demonstrated that tumors with
adrenal gland invasion carry a worse prognosis than
perinephric fat or renal vein invasion in patients with pT3
disease and they were found as an independent predictor
of a patient’s overall survival (28). Therefore, the

detection of adrenal gland involvement is very important
in patients with RCC.
Presence of lymph node involvement
In accordance with the literature, presence of LN
involvement was found to be significantly associated with
adrenal involvement in our study (Table 2) (8,12,26,27).
Presence of metastasis
Although metastatic disease was not found to be
associated with adrenal involvement in our study (Table
2), previous studies demonstrated that M+ disease was a
risk factor for adrenal metastasis by RCC
(8,9,12,18,26,27).

Conclusions
We recommend ipsilateral adrenalectomy with RN
particularly in patients with increased tumor size,
pathologic stage, localization of the tumor in the upper
pole of the kidney, in the presence of adrenal gland
irregularity/abnormality on CT scans, and with other
possible risk factors (Table 4).
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